Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
MCK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$464.42 - $728.32
Previous CloseN/A
Volume137.88K
Average Volume (3M)967.88K
Market Cap
$89.85B
Enterprise Value$81.01B
Total Cash (Recent Filing)$1.13B
Total Debt (Recent Filing)$9.76B
Price to Earnings (P/E)32.9
Beta0.27
Next Earnings
May 08, 2025EPS Estimate
9.81Last Dividend Ex-Date
Mar 03, 2025Dividend Yield0.4%
Share Statistics
EPS (TTM)21.82
Shares Outstanding125,326,380
10 Day Avg. Volume1,053,195
30 Day Avg. Volume967,883
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.24
Price to Cash Flow (P/CF)-8.70
P/FCF Ratio0.00
Enterprise Value/Market Cap0.90
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.44
Enterprise Value/Ebitda16.36
Forecast
1Y Price Target
$711.50Price Target Upside4.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
---
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe PRISM acquisition is expected to contribute an estimated $90 million in EBITDA to McKesson's 2026 pro forma post-deal adjusted EBITDA.
Earnings And PerformanceUS Pharma is clearly exiting FY25 from a position of strength and is set up for ongoing strong EBIT growth in FY26 as utilization remains strong, specialty assets shine, and recent acquisitions contribute to growth.
Industry OutlookThe overall outlook for the U.S. drug distribution industry remains robust, supported by consistent brand drug price inflation and favorable generic drug price trends.
Bears Say
Performance MissPrescription Technology Solutions missed modestly on EBIT.
Segment WeaknessMed-Surg's outlook is a lot less clear, with quarterly results impacted by a primary care market that has remained weak.
Valuation ConcernsValuation feels relatively full when compared to significant discounts across much of the coverage universe, leading to an 'Equal' recommendation.
---
Ownership Overview
0.06% Insiders
24.02% Mutual Funds
17.63% Other Institutional Investors
37.10% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $464.42 and its highest was $728.32 in the past 12 months.
What is Mckesson Corp.’s market cap?
Mckesson Corp.’s market cap is $89.85B.
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is May 08, 2025 which is in 32 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Feb 05, 2025. The company reported $8.03 earnings per share for the quarter, beating the consensus estimate of $7.989 by $0.041.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.709 which represents an annual dividend yield of 0.4%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is 9.81.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 125,326,380 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $8.03 in its last earnings report, beating expectations of $7.989. Following the earnings report the stock price went down -1.179%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Currently, no hedge funds are holding shares in MCK
---
McKesson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$711.50 (4.16% Upside)
$711.50 (4.16% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 91%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 556.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.2%
Last 30 Days ▲ 11.4%
Last 30 Days ▲ 11.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.32%
12-Months-Change
Fundamentals
Return on Equity
51.23%
Trailing 12-Months
Asset Growth
6.87%
Trailing 12-Months
Company Description
Mckesson Corp.
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. Founded in 1833 and headquartered in Irving, Texas, McKesson operates in various sectors, primarily focusing on the distribution of pharmaceuticals and medical products, delivering comprehensive pharmacy solutions, and offering technology-driven healthcare solutions to improve patient care and outcomes.
---
MCK Company Deck
---
MCK Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong financial performance with significant revenue and profit growth, driven by strategic acquisitions and expansions in specialty services. Despite challenges in the Medical Surgical segment and some revenue impacts due to formulary changes, the company's raised guidance and strong segment growth indicate a positive outlook.Read More>---
MCK Revenue Breakdown
90.22% U.S. Pharmaceutical
4.57% International
3.66% Medical-Surgical Solutions
1.54% Prescription Technology Solutions
---
MCK Stock 12 Month Forecast
Average Price Target
$711.50
▲(4.16% Upside)
Technical Analysis
Best Analysts Covering MCK
1 Year
1 Year Success Rate
23/25 ratings generated profit
1 Year Average Return
+30.13%
reiterated a buy rating 5 days ago
Copying Michael Cherny's trades and holding each position for 1 Year would result in 92.00% of your transactions generating a profit, with an average return of +30.13% per trade.
---